Direct Healthcare Cost and Resources Utilization of Malaria among Households in Madani Locality, Gezira State. Sudan
Authors
Epidemiologist, Directorate General of Health Emergency and Epidemic Control, Federal Ministry of Health (Sudan)
Associate Professor, Buraimi University College, Business Administration and Accounting Department (Oman)
Article Information
Publication Timeline
Submitted: 2026-01-16
Accepted: 2026-01-22
Published: 2026-02-05
Abstract
Background: Malaria continues to pose a significant health and economic challenge in Sudan, imposing substantial out-of-pocket expenditures and Catastrophic Health Expenditure (CHE) for affected households. This study aims to estimate direct healthcare costs, analyze healthcare resource utilization, and identify socioeconomic and demographic predictors of the economic burden of malaria in Madani Locality, Gezira State.
Methodology: A community-based study was conducted in 2017 among 385 households selected through multi-stage sampling. Data on direct treatment expenditure (consultation fees, laboratory tests, drugs, special food, transportation, and other costs) and healthcare-seeking behaviors were collected via a piloted questionnaire. Statistical analysis employed descriptive methods, ANOVA, Chi-square tests, and multiple regression to assess cost distribution and predictors of economic burden.
Results: Drugs constituted the highest proportion of direct treatment costs (107.61 SDG / 16.3 USD), followed by special food (38, 78 SDG / 5.7 USD). Pharmacies were the most common treatment source (11.77 SDG / 1.7 USD per case). Public health centers were the most common treatment source (47.3%), with proximity (53%) the primary reason for facility choice. Regression analysis identified socioeconomic status (p=0.001), occupation of household head (p=0.01), age (p=0.01), gender (p=0.03), and use of preventive methods (p=0.02) as significant predictors of economic burden, while diagnostic method and facility choice were not significant. These findings highlight that structural socioeconomic conditions outweigh service-level factors in shaping household vulnerability to Catastrophic Health Expenditure (CHE).
Conclusion: Malaria impose substantial and catastrophic financial burden on households in Sudan, driven primarily by poverty, occupation, gender, and age. Preventive methods were protective, reducing household vulnerability. The study contributes to debates on Universal Health Coverage (UHC) and malaria financing by demonstrating that socioeconomic determinants, rather than service-level factors, are decisive in predicting Catastrophic Health Expenditure (CHE). Strengthening drug availability in public facilities, expanding insurance coverage, and prioritizing preventive interventions are critical to reducing economic vulnerability, advancing HUC, and achieving global malaria control targets.
Keywords
Malaria, Economic Burden, Catastrophic Health Expenditure, Universal Health Coverage, Sudan.
Downloads
References
1. Mamoun Ahmed. The Impact of Malaria Disease on Socio-Economic Development in the Gezira Scheme, Sudan. (2015). [Google Scholar] [Crossref]
2. Onwujekwe O, Malik E, Mustafa SH, Mnzavaa A. Do malaria preventive interventions reach the poor? Socioeconomic inequities in expenditure on and use of mosquito control tools in Sudan. Health Policy and Planning. 2006;21(1):10–16. [Google Scholar] [Crossref]
3. Anteneh Lamesgen et al. The economic burden of malaria in Africa: a systematic review of cost of illness studies. Malaria Journal. 2025;24:223. [Google Scholar] [Crossref]
4. Wafula ST, Habermann T, Franke MA, May J, Puradiredja DI, Lorenz E, Brinkel J. What are the pathways between poverty and malaria in sub-Saharan Africa? A systematic review of mediation studies. Infectious Diseases of Poverty. 2023;12:58. [Google Scholar] [Crossref]
5. United Nations Western Europe. Malaria: a disease of poverty. UN Report, 2021. [Google Scholar] [Crossref]
6. Severe Malaria Observatory. Malaria in Sudan: statistics & facts. 2024. https://www.severemalaria.org [Google Scholar] [Crossref]
7. Sachs J, Malaney P.The economic and social burden of malaria. Nature. 2002;415(6872):680‑685. doi:10.1038/415680a [Google Scholar] [Crossref]
8. Gallup JL, Sachs JD, Mellinger AD. The economic burden of malaria. Am J Trop Med Hyg. 2001;64(1‑2 Suppl):85‑96. [Google Scholar] [Crossref]
9. Chima RI, Goodman CA, Mills A. The economic impact of malaria in Africa: a critical review of the evidence. Health Policy. 2003;63(1):17‑36. doi:10.1016/S0168-8510(02)00036-2 [Google Scholar] [Crossref]
10. Lamesgen A, Engidaw M, Gedif G, Gete M, Belay YA.The economic burden of malaria in Africa: a systematic review of cost‑of‑illness studies. Malar J. 2025;24:223. doi:10.1186/s12936‑025‑04987‑y [Google Scholar] [Crossref]
11. Anteneh Lamesgen et al. The economic burden of malaria in Africa: a systematic review of cost of illness studies. Malaria Journal. 2025;24:223. [Google Scholar] [Crossref]
12. Andrade MV, Noronha K, Diniz BPC, Guedes G, Carvalho LR, Silva VA, Calazans JA, Santos AS, Silva DN, Castro MC. The economic burden of malaria: a systematic review. Malar J. 2022;21:283. doi:10.1186/s12936-022-04292-9. [Google Scholar] [Crossref]
13. World malaria report 2023. Geneva: WHO; 2023. [Google Scholar] [Crossref]
14. Banda R, Chirwa GC, Phiri M, et al. Household catastrophic health expenditure due to malaria in Sub-Saharan Africa: evidence from multi-country surveys. Dev Stud Res. 2024;12(1):1-15. [Google Scholar] [Crossref]
15. doi:10.1080/21665095.2025.2481830 [Google Scholar] [Crossref]
16. Eze P, Lawani LO, Agu UJ, Acharya Y. Catastrophic health expenditure in sub-Saharan Africa: systematic review and meta-analysis. Bull World Health Organ. 2022;100(5):337-351. doi:10.2471 [Google Scholar] [Crossref]
17. Federal Ministry of Health. Annual health statistical report 2022. Khartoum: Federal Ministry of Health; 2022. [Google Scholar] [Crossref]
18. 17 Eltahir EM, Mohamed EA, Elhassan IM.Malaria epidemiology in Gezira State, Sudan: trends and determinants of transmission. Sudan J Med Sci. 2021;16(3):245‑256. [Google Scholar] [Crossref]
19. Babiker A, Gadalla N, Ranford‑Cartwright L.The epidemiology of malaria in Sudan: linking transmission patterns to control strategies. Trans R Soc Trop Med Hyg. 2019;113(12):799‑807. doi:10.1093/trstmh/trz087 [Google Scholar] [Crossref]
20. Mustafa M, Babiker M. The economic burden of malaria on households in Khartoum State, Sudan. East Mediterr Health J. 2004;10(1-2):46-54. [Google Scholar] [Crossref]
21. Mohamed E. Household costs of malaria treatment in Sudan: microeconomic evidence from Khartoum. Sudan J Public Health. 2009;4(2):123-129. [Google Scholar] [Crossref]
22. Elhadi YA, Ahmed A, Ghazy RM, Salih EB, Abdelhamed OS, Shaaban R, et al.Healthcare utilization with drug acquisition and expenses at the National Health Insurance Fund in Sudan. Healthcare (Basel). 2022;10(4):630. doi:10.3390/healthcare10040630 [Google Scholar] [Crossref]
23. Hemmeda L, Koko AEA, Mohamed RF, Abdallah MYI, Elabid AOM, Omer AT, et al.Accessibility crisis of essential medicines at Sudanese primary healthcare facilities: a cross‑sectional dispensary assessment and patients’ perspectives. Int J Equity Health. 2023;22:216. [Google Scholar] [Crossref]
24. doi:10.1186/s12939‑023‑01916‑7 [Google Scholar] [Crossref]
25. Sudan National Health Insurance Fund (NHIF): Assessment of institutional arrangements and analysis of income and expenditure. Geneva: ILO; 2025. [Google Scholar] [Crossref]
26. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. [Google Scholar] [Crossref]
27. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015. [Google Scholar] [Crossref]
28. Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327-337. doi:10.3350/cmh.2014.20.4.327 [Google Scholar] [Crossref]
29. Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32(4):335-344. doi:10.1007/s40273-014-0143-y [Google Scholar] [Crossref]
30. Conteh L, Sicuri E, Manzi F, et al. The cost-effectiveness of malaria interventions in Africa: a systematic review. Malar J. 2020;19:349. doi:10.1186/s12936-020-03483-9 [Google Scholar] [Crossref]
31. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL.Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362(9378):111–7. doi:10.1016/S0140-6736(03)13861-0 [Google Scholar] [Crossref]
32. Andersen RM.Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1‑10. doi:10.2307/2137284 [Google Scholar] [Crossref]
33. Aday LA, Andersen R.A framework for the study of access to medical care. Health Serv Res. 1974;9(3):208‑220 [Google Scholar] [Crossref]
34. Becker GS. The economics of discrimination. Chicago: University of Chicago Press; 1957. [Google Scholar] [Crossref]
35. Snyman K, Pitt C, Aturia A, Aber J, Gonahasa S, Namuganga JF, et al. Who pays to treat malaria and how much? Analysis of the cost of illness, equity and economic burden of malaria in Uganda. Health Policy Plan. 2025;40(1):52‑65. [Google Scholar] [Crossref]
36. Sicuri E, Vieta A, Lindner L, Constenla D, Sauboin C. The economic cost of malaria in four countries in sub‑Saharan Africa: Ghana, Nigeria, Tanzania, and Uganda. Malar J. 2013;12:307. [Google Scholar] [Crossref]
37. Akazili J, Aikins M, Nkrumah F, Gyapong J. Cost to households of seeking malaria care in the Kassena‑Nankana district of Ghana. Trop Med Int Health. 2002;7(9):856‑864. [Google Scholar] [Crossref]
38. Onwujekwe O, Hanson K, Uzochukwu B, Ichoku H, Ike E, Onwughalu B. Examining catastrophic costs and impoverishment due to malaria treatment in Nigeria. Trop Med Int Health. 2006;11(3):294‑301. [Google Scholar] [Crossref]
39. Sicuri E, Davy C, Marinelli M, Ouedraogo S, Ouedraogo A, et al. Household costs of malaria in Mali: the hidden burden on the poor. Malar J. 2011;10:167. [Google Scholar] [Crossref]
40. Snyman K, Pitt C, Aturia A, Aber J, Gonahasa S, Namuganga JF, et al. Who pays to treat malaria and how much? Analysis of the cost of illness, equity and economic burden of malaria in Uganda. Health Policy Plan. 2025;40(1):52-65. [Google Scholar] [Crossref]
41. PLOS Global Public Health. Stock-outs and patient trust in malaria case management in rural Kenya. PLOS Glob Public Health. 2023;3(7):e0001452. [Google Scholar] [Crossref]
42. 2023 Systematic Review:Wafula ST, Habermann T, Franke MA, May J, Puradiredja DI, Lorenz E, Brinkel J. What are the pathways between poverty and malaria in sub‑Saharan Africa? A systematic review of mediation studies. Infect Dis Poverty. 2023;12:58. doi:10.1186/s40249-023-01102-9 [Google Scholar] [Crossref]
43. 2025 doctoral dissertation (systematic review focus),Wafula ST. Pathways linking socioeconomic position and malarial infection and healthcare‑seeking behaviour for suspected malaria in sub‑Saharan Africa [dissertation]. Hamburg: University of Hamburg; 2025. [Google Scholar] [Crossref]
44. Gbaguidi GJ, Topanou N, Leal Filho W, Begedou K, Ketoh GK. Environmental and socio‑economic determinants of malaria transmission in West Africa: a systematic review. One Health Outlook. 2025;7:47. [Google Scholar] [Crossref]
45. PLOS Global Public Health. Improving socioeconomic status may reduce the burden of malaria. PLOS Glob Public Health. 2024;2(11):e000245. [Google Scholar] [Crossref]
46. Alfonso YN, Lynch M, Mensah E, Piccinini D, Bishai D. Willingness‑to‑pay for long‑lasting insecticide‑treated bed nets: a discrete choice experiment in Ghana. Malar J. 2020;19:14. [Google Scholar] [Crossref]
47. Shretta R, Ngwafor RA. An investment case for the scale‑up and use of insecticide‑treated nets halfway into the SDG targets. J Benefit‑Cost Anal. 2023;14(S1):S1‑S23. [Google Scholar] [Crossref]
48. Ayoka TO, Upaganlawar A, Nnadi CO. Predictive modeling of malaria prevalence using socioeconomic, environmental, and demographic determinants across age and gender groups in Nigeria. Discover Public Health. 2025;22:874. [Google Scholar] [Crossref]
49. Regional synthesis. Gender dimensions of malaria burden. Public Health Review. 2024;39:112. [Google Scholar] [Crossref]
50. Assebe LF, Dillu D, Tiru G, Johansson KA, Bolongaita S, Chakrabarti A, Hendrix N.Financial risks of care seeking for malaria by rural households in Jimma Zone, Oromia Region, Southwest Ethiopia: a cross‑sectional study. BMJ Open. 2021;11:e056162. doi:10.1136/bmjopen‑2021‑056162 [Google Scholar] [Crossref]
51. Tadiwos YB, Kassahun MM, Mebratie AD.Catastrophic and impoverishing out‑of‑pocket health expenditure in Ethiopia: evidence from the Ethiopia socioeconomic survey. Health Econ Rev. 2025;15:15. doi:10.1186/s13561‑025‑00587‑9 [Google Scholar] [Crossref]
52. Assefa T, Belachew T, Tegegne B.Health‑seeking behavior for malaria among rural households in Ethiopia: evidence from Oromia Region. Malar J. 2019;18:320. doi:10.1186/s12936‑019‑2960‑y [Google Scholar] [Crossref]
53. Thuilliez J.Malaria and primary education in Mali: the impact of disease on school performance. Malar J. 2010;9:3. doi:10.1186/1475‑2875‑9‑3 [Google Scholar] [Crossref]
54. Russell S. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and HIV/AIDS. Trop Med Int Health. 2004;9(3):297‑305. doi:10.1111/j.1365‑3156.2004.01208.x [Google Scholar] [Crossref]
55. World Health Organization (WHO). Sudan Pharmaceutical Country Profile. Geneva: WHO; 2011. [Google Scholar] [Crossref]
56. Cameron A, Ewen M, Ross‑Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle‑income countries: a secondary analysis. Lancet. 2009;373(9659):240‑249. doi:10.1016/S0140‑6736(08)61762‑6 [Google Scholar] [Crossref]
57. Fernando SD, Gunawardena DM, Bandara MR, et al.The impact of repeated malaria attacks on school performance of children in Sri Lanka. Am J Trop Med Hyg. 2003;69(6):582‑588. [Google Scholar] [Crossref]
58. Scates SS, Finn TP, Wisniewski J, Dadi D, Mandike R, Khamis M, et al. Costs of insecticide‑treated bed net distribution systems in sub‑Saharan Africa. Malar J. 2020;19:105. [Google Scholar] [Crossref]
59. Hlongwana KW, et al. Effectiveness and cost‑effectiveness of reactive, targeted indoor residual spraying for malaria control in low‑transmission settings: a cluster‑randomised trial in South Africa. Lancet. 2021;397(10276):816‑827. [Google Scholar] [Crossref]
60. Irish SR, Nimmo D, Bharmel J, Tripet F, Müller P, Manrique‑Saide P, Moore SJ. A review of selective indoor residual spraying for malaria control. Malar J. 2024;23:252. [Google Scholar] [Crossref]
61. Anjorin S, Okolie E, Yaya S. Malaria profile and socioeconomic predictors among under‑five children: an analysis of 11 sub‑Saharan African countries. Malar J. 2023;22:55. [Google Scholar] [Crossref]
62. Ewen M, Kaplan W, Gedif T, Justin‑Temu M, Vialle‑Valentin C, Mirza Z, et al. Prices and availability of medicines in Ethiopia, Tanzania, and Malawi. PLoS Med. 2017;14(11):e1002369. doi:10.1371/journal.pmed.1002369 [Google Scholar] [Crossref]
63. Levin KA.Study design III: Cross‑sectional studies. Evid Based Dent. 2006;7(1):24‑25. doi:10.1038/sj.ebd.6400375 [Google Scholar] [Crossref]
64. Setia MS.Methodology series module 3: Cross‑sectional studies. Indian J Dermatol. 2016;61(3):261‑264. doi:10.4103/0019‑5154.182410 [Google Scholar] [Crossref]
65. Mann CJ.Observational research methods. Research design II: cohort, cross‑sectional, and case‑control studies. Emerg Med J. 2003;20(1):54‑60. doi:10.1136/emj.20.1.54 [Google Scholar] [Crossref]
66. Grimes DA, Schulz KF. Descriptive studies: what they can and cannot do. Lancet. 2002;359(9301):145‑149. doi:10.1016/S0140‑6736(02)07373‑7 [Google Scholar] [Crossref]
67. Rice DP.Estimating the cost of illness. Am J Public Health. 1967;57(3):424‑440. doi:10.2105/AJPH.57.3.424 [Google Scholar] [Crossref]
68. Weissman JS, Gatsonis C, Epstein AM.Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland. JAMA. 1992;268(17):2388‑2394. doi:10.1001/jama.1992.03490170070033 [Google Scholar] [Crossref]
69. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L.The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171‑189. doi:10.1016/0167‑6296(94)00044‑H [Google Scholar] [Crossref]
70. Elagali A, Ahmed A, Makki N, Ismail H, Ajak M, Addis Alene K, et al.Spatiotemporal mapping of malaria incidence in Sudan using routine surveillance data. Sci Rep. 2025;15:1442. doi:10.1038/s41598‑025‑01442‑7 [Google Scholar] [Crossref]
71. UNICEF.Ongoing conflict disrupts efforts to control malaria and threatens health of millions of children in Sudan. Press release, 25 April 2025. [Google Scholar] [Crossref]
72. Shiff C, Checkley W, Winch P, Premji Z, Minjas J, Lubega P. Changes in weight gain and anaemia attributable to malaria in Tanzanian children living under holoendemic conditions. Trans R Soc Trop Med Hyg. 1996;90(3):262‑265. [Google Scholar] [Crossref]
73. Jo C. Cost‑of‑illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327‑337. doi:10.3350/cmh.2014.20.4.327 [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- Migrant Health in Morocco: Between Law and Reality
- CaknaMinda: An Educator-Centred Mobile App for Early Screening of Mental Health and Schizophrenia Risks
- Health System and Nursing Strategies for Enhancing Male Participation in Family Planning: Evidence from Tema General Hospital, Ghana.
- From Īśvara-Praṇidhāna to Parā-Bhakti: Convergent Paths of Aṣṭāṅga Yoga and Bhakti Yoga
- Evidence-Based Psycho-Oncological Interventions: A Multimodal Approach to Supportive Care